<?xml version="1.0" encoding="UTF-8"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-10-19T01:10:10Z</responseDate><request verb="GetRecord" identifier="oai:ebyu-rdlopen.rawdatalibrary.net:ebyu/11912" metadataPrefix="oai_dc">https://ebyu-rdlopen.rawdatalibrary.net/oai/request</request><GetRecord><record><header><identifier>oai:ebyu-rdlopen.rawdatalibrary.net:ebyu/11912</identifier><datestamp>2026-10-18T21:13:16Z</datestamp><setSpec>openaire</setSpec><setSpec>driver</setSpec><setSpec>com_ebyu_10000</setSpec><setSpec>col_ebyu_10001</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><dc:title>The Protective Effect of Gallic Acid Against Bisphenol A-Induced Ovarian Toxicity and Endocrine Disruption in Female Rats</dc:title><dc:creator>Gezer, Arzu</dc:creator><dc:creator>Üstündag, Hilal</dc:creator><dc:creator>Kılıç Baygutalp, Nurcan</dc:creator><dc:creator>Erbaş, Elif</dc:creator><dc:creator>Özkaraca, Mustafa</dc:creator><dc:subject>bisphenol A toxicity</dc:subject><dc:subject>endocrine disruption</dc:subject><dc:subject>gallic acid</dc:subject><dc:subject>inflammatory markers</dc:subject><dc:subject>ovarian histopathology</dc:subject><dc:subject>oxidative</dc:subject><dc:subject>stress parameters</dc:subject><dc:subject>8-Hydroxy-2'-Deoxyguanosine</dc:subject><dc:subject>Animals</dc:subject><dc:subject>Antioxidants</dc:subject><dc:subject>Apoptosis</dc:subject><dc:subject>Benzhydryl Compounds</dc:subject><dc:subject>Cyclooxygenase 2</dc:subject><dc:subject>DNA Damage</dc:subject><dc:subject>Endocrine Disruptors</dc:subject><dc:subject>Female</dc:subject><dc:subject>Follicle Stimulating Hormone</dc:subject><dc:subject>Humans</dc:subject><dc:subject>Interleukin-1beta</dc:subject><dc:subject>Luteinizing Hormone</dc:subject><dc:subject>Malondialdehyde</dc:subject><dc:subject>Ovary</dc:subject><dc:subject>Oxidative Stress</dc:subject><dc:subject>Phenols</dc:subject><dc:subject>Progesterone</dc:subject><dc:subject>Protective Agents</dc:subject><dc:subject>Rats</dc:subject><dc:subject>Rats, Sprague-Dawley</dc:subject><dc:subject>Superoxide Dismutase</dc:subject><dc:subject>Tumor Necrosis Factor-alpha</dc:subject><dc:description>Purpose: This study aimed to investigate the protective effects of gallic acid (GA) against ovarian damage induced by bisphenol A (BPA) exposure in female rats. We evaluated whether GA can mitigate the adverse effects of BPA on ovarian structure, inflammatory markers, oxidative stress, apoptosis, and reproductive hormone levels. Methods: Thirty-two female rats were categorized into four groups: control, GA, BPA, and GA+BPA. Histopathological evaluations of ovarian tissue were performed using hematoxylin-eosin staining. The immunohistochemical analysis was conducted for inflammatory, oxidative DNA damage, and apoptotic markers (Tumor necrosis factor alpha [TNFa], cyclooxygenase-2 [COX2], interleukin-1 beta [IL-1b], 8-hydroxydeoxyguanosine [8-OHdG], and caspase 3). Oxidative stress was assessed by measuring malondialdehyde and superoxide dismutase levels. Furthermore, follicle-stimulating hormone (FSH), luteinizing hormone (LH), estrogen, and progesterone levels were quantified using enzyme-linked immunosorbent assay. Results: Histopathological outcomes revealed that BPA significantly induced follicular degeneration, which was effectively mitigated by GA treatment (P &lt; 0.05). Immunohistochemical analysis highlighted the exacerbation of inflammatory responses and oxidative DNA damage and apoptosis (TNFa, COX-2, IL-1b, 8-OHdG, and caspase 3) in BPA-exposed tissues, which were reduced in the presence of GA (P &lt; 0.05). The assessment of oxidative stress demonstrated that GA could significantly decrease lipid peroxidation and partially restore antioxidant defense mechanisms disrupted by BPA (P &lt; 0.05). Hormonal profiling indicated that BPA exposure altered the levels of FSH, LH, estrogen, and progesterone, with GA treatment showing a capacity to modulate these changes, especially in progesterone levels (P &lt; 0.05). Conclusions: The findings suggest that GA exhibits protective properties against BPA-induced ovarian damage through its antioxidative and anti-inflammatory activities, alongside its ability to modulate hormonal imbalances. This research underscores the therapeutic potential of GA in safeguarding reproductive health against environmental toxicants. © Mary Ann Liebert, Inc., and Korean Society of Food Science and Nutrition.</dc:description><dc:publisher>Mary Ann Liebert Inc.</dc:publisher><dc:date>2024</dc:date><dc:type>Article</dc:type><dc:identifier>https://rdlopen.rawdatalibrary.net/r/ebyu/11912</dc:identifier><dc:identifier>https://doi.org/10.1089/jmf.2024.0088</dc:identifier><dc:identifier>1096-620X</dc:identifier><dc:language>en</dc:language><dc:relation>Journal of Medicinal Food</dc:relation><dc:rights>info:eu-repo/semantics/openAccess</dc:rights><dc:type>info:eu-repo/semantics/article</dc:type><dc:identifier>https://ebyu-rdlopen.rawdatalibrary.net/tr/items/ebyu/11912</dc:identifier></oai_dc:dc></metadata></record></GetRecord></OAI-PMH>